January 9, 2023
A multi-institutional national study has identified unique molecular features responsible for the development and progression of metastatic breast cancer.
March 15, 2022
Chad Pecot, MD, and colleagues used biospecimens from a patient just after he succumbed to lung cancer to unravel how a KRAS mutation developed resistance to a treatment that had initially proved effective.
December 3, 2021
Researchers led by Hector L. Franco, PhD, have determined for the first time, cell-by-cell, the genetic and epigenetic state of ovarian and endometrial tumors.
November 20, 2020
Clarivate’s 2020 Highly Cited Researchers list recognized 15 UNC Lineberger members for publishing some of the most influential scientific papers the past decade.
June 24, 2020
UNC Lineberger faculty have held leadership and team membership roles with The Cancer Genome Atlas, which was launched in 2006.
June 13, 2019
Using a new blood test that’s in development, University of North Carolina Lineberger Comprehensive Cancer Center researchers identified characteristics that could be used to personalize treatment for patients with a type of head and neck cancer linked to HPV infection. Researchers believe the findings, published in the journal Clinical Cancer Research, could help identify those …
February 28, 2019
A pair of studies led by University of North Carolina Lineberger Comprehensive Cancer Center researchers could aid in improved diagnosis for melanoma, the deadliest form of skin cancer. The studies, led by UNC Lineberger’s Nancy Thomas, MD, PhD, Irene & Robert Alan Briggaman Distinguished Professor and Chair in the UNC School of Medicine Department of …
July 19, 2018
In a study published in the journal Science, researchers led by UNC Lineberger's Qing Zhang, PhD, suggest that ZHX2 is a potential new therapeutic target for clear cell renal cell carcinoma, which is the most common type of kidney cancer.
